Analystreport

Recro Pharma Inc (NASDAQ: REPH) is now covered by analysts at CIBC. They set an "outperform" rating and a $19.00 price target on the stock.

Recro Pharma, Inc.  (REPH) 
Last recro pharma, inc. earnings: 11/8 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.recropharma.com